Shipment company

Arrival of the second shipment of Moderna bivalent vaccine

Priority groups such as the elderly and immunocompromised can schedule a booster shot with the new vaccine, possibly as early as today

  • By Lee I-chia / Staff Reporter

A second shipment of the bivalent COVID-19 Moderna vaccine, consisting of 803,000 doses, arrived in Taoyuan yesterday, said the Central Epidemic Command Center (CECC), which reported 39,330 new local cases.

The doses expire on March 29 next year and are due to be sent to local governments next month, he said.

The second-generation bivalent vaccine — which targets the Omicron variant of SARS-CoV-2 with the original 2019 strain — is to be used as a booster shot, the center said.

Photo courtesy of Central Epidemic Command Center

People aged 65 and over, residents of long-term care facilities and people with compromised immune systems are prioritized, he said.

Taiwan signed a contract with US biotech firm Moderna Inc in July last year to receive 35 million doses of COVID-19 vaccines within two years, with 20 million expected to arrive this year.

Taiwan has received 1,124,300 doses of COVID-19 vaccines this year, he said.

The Deputy Director General of the Centers for Disease Control (CDC), Chuang Jen-hsiang (莊人祥), who is the spokesperson for the CECC, said yesterday that the first shipment of the bivalent vaccine Moderna, which arrived on Friday last week and consists of 803,000 doses, was due to be delivered to local governments from Saturday to early next month.

Those in a priority group can check their local health department’s website for information about scheduling appointments, which could start today in some areas, Chuang said.

Meanwhile, 39,330 new local COVID-19 cases, 239 imported cases and 39 deaths were reported yesterday, and the number of local cases increased by 23.5% compared to Sunday last week, it said. he declares.

The 39 people who died were all aged 50 and over, including 36 people with chronic health conditions and 24 who did not receive a booster, according to CECC data.

Of the 157 new moderate and severe cases, Chuang said one case is a 2-year-old boy, who received a vaccine dose on July 26, but was diagnosed with COVID-19 on August 13 and developed fever on September 5, cough, runny nose, congestion and diarrhea.

The boy had mild pneumonia when he was taken to the emergency room on September 10, and a blood test showed he had a bacterial infection, Chuang said.

The boy was diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C), and his condition improved after being transferred to a medical center last Thursday, he added.

Additional reports by CNA

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. The final decision will be at the discretion of the Taipei Times.